Therapeutic Areas

Our extensive expertise spans all therapeutic areas, ensuring that we can provide tailored support for your specific needs across the entire product lifecycle. Our proficiency covers small molecules, biologics, devices and combination products, addressing both common and rare diseases.

This diverse experience enables our experts to maximise the value of your products, ensuring optimal outcomes. Whether your project requires a comprehensive development programme or specialist service, we are committed to accelerating your journey from product translation to prescription.

Oncology

We specialise in designing and delivering oncology programmes. Our expertise includes targeted treatments, immunotherapies, vaccines, cell-based products, and innovative cytotoxics.

Read more

Infectious Diseases

With a rich heritage in infectious diseases, tranScrip brings the expertise needed to help clients develop groundbreaking treatments for these critical health challenges.

Read more

Immunology

tranScrip’s extensive expertise in immunology covers small molecules as well as monoclonal antibodies, cell therapy, antisense oligo-nucleotides and gene therapy.

Read more

Neurology

Our expertise in neurology covers a broad spectrum of conditions, including epilepsy, neurodegenerative diseases, stroke, sleep disorders, depression, schizophrenia, ADHD, and pain.

Read more

Respiratory

tranScrip's teams are experts in a wide range of respiratory conditions, from common issues like asthma, COPD, and allergies to rare diseases such as cystic fibrosis and idiopathic pulmonary fibrosis.

Read more

Rare Diseases

Our experts possess the experience needed to develop innovative strategies for delivering treatments for rare and orphan diseases to patients across all therapeutic areas.

Read more

“I have worked with tranScrip on several occasions, in my previous capacity as Head of Development and Chief Medical Officer at Polyphor AG and in my previous role as Chief Medical Officer at Polyneuron AG.

Services tranScrip have provided in the therapeutic areas of oncology, infectious diseases, neurology and rare diseases have ranged from protocol writing, manuscript writing, drug safety, clinical pharmacology and microbiology. To simply state that they have delivered consistently and to a high standard of quality would badly understate the impact they have had on the performance and ability of the companies to execute and deliver on key investor and regulatory milestones. Strategic oncology input enabled us to design a winning oncology strategy, deliver a publication in a Key Journal in time for IPO and write the protocol for the pivotal study. tranScrip’s staff were able to integrate seamlessly and work (remotely) as a full value adding part of the team. This delivering as part of the team was also seen in the drug safety and clinical pharmacology support where tranScrip employees integrate to the team and add value from their general drug development experience, as well as their specific area of key focus, both of which are appreciated.

As well as proactive ongoing support, tranScrip have also demonstrated their effectiveness on “emergency interventions”, able to pull a team together at short notice for a deep dive into a problem after regulatory advice has been received. The quality of the technical input and contribution to problem solving is impressive, as well as the higher level drug development and safety expertise to participate in the development of overarching and comprehensive effective solutions.”

Debra Barker

Chief Medical Officer

Destiny Pharma

Contact Us

Our experienced physicians and scientists, together with our regulatory, clinical and commercial experts can support you to maximise the value of your products. Whatever your project requires, we have the expertise to meet your needs.

Get in touch